14-Cinnamoyloxycodeinone CAS: 751-01-9

CAS NO: 751-01-9
14-Cinnamoyloxycodeinone
Chemical Name: 3-Phenylpropenoic acid 7,8-didehydro-4,5α-epoxy-3-methoxy-17-methyl-6-oxomorphinan-14-yl ester
Molecular Formula: C27H25NO5
Formula Weight: 443.49
CAS No.: 751-01-9
Description Review
Description

14-Cinnamoyloxycodeinone, also known by its CAS number 751-01-9, is a chemical compound that is used primarily in the pharmaceutical industry as an analgesic agent. This powerful pain reliever is derived from codeine, a naturally occurring opioid alkaloid found in opium poppy plants.

Chemical name: (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol cinnamate Molecular formula: C29H31NO5 Formula weight: 473.6 grams/mol CAS No: 751-01-9

Top ten keywords from Google and Synonyms:

  1. 14-Cinnamoyloxycodeinone
  2. CAS: 751-01-9
  3. Codeine derivative
  4. Analgesic agent
  5. Cinnamoyloxycodeinone
  6. Opioid alkaloid
  7. Pain relief
  8. Pharmaceutical industry
  9. Codeine analog
  10. Chemical compound

Health Benefits of this Product:

As an analgesic agent, 14-Cinnamoyloxycodeinone has a number of potential health benefits. This compound works by binding to specific receptors in the brain and spinal cord that are responsible for mediating the sensation of pain, making it useful in treating a variety of conditions.

For example, 14-Cinnamoyloxycodeinone has been shown to be effective in the treatment of acute and chronic pain, including pain associated with cancer, surgical procedures, and other medical conditions. Additionally, this compound has been used to manage pain in patients who are not able to tolerate other pain medications, such as non-steroidal anti-inflammatory drugs (NSAIDs).

Potential Effects:

The potential effects of 14-Cinnamoyloxycodeinone are primarily related to its analgesic properties. When used appropriately, this compound can provide effective and long-lasting pain relief, making it a useful tool in the management of various medical conditions.

However, as an opioid derivative, 14-Cinnamoyloxycodeinone also has the potential for abuse and addiction, making it important to use this compound only as directed and under the supervision of a healthcare professional.

Product Mechanisms:

14-Cinnamoyloxycodeinone works by binding to specific receptors in the brain and spinal cord that are responsible for mediating the sensation of pain. Specifically, this compound binds to mu-opioid receptors, which are found primarily in the brain and spinal cord.

By binding to these receptors, 14-Cinnamoyloxycodeinone can activate a series of downstream signaling events that ultimately result in the inhibition of pain transmission. This, in turn, provides effective and long-lasting pain relief.

Safety:

While 14-Cinnamoyloxycodeinone is generally safe when used appropriately, this compound is also associated with a number of potential risks and side effects. For example, as an opioid derivative, this compound has the potential for abuse and addiction, particularly when used in high doses or over long periods of time.

Additionally, 14-Cinnamoyloxycodeinone can cause a number of side effects, including drowsiness, dizziness, constipation, and respiratory depression. In rare cases, this compound can also cause more serious side effects, such as seizures, hallucinations, and cardiac arrest.

Overdose of this compound can be fatal, making it important to use 14-Cinnamoyloxycodeinone only as directed and under the guidance of a qualified healthcare professional.

Dosing Information:

The appropriate dose of 14-Cinnamoyloxycodeinone will depend on a number of factors, including the individual's age, weight, and medical history. As with any medication, it is important to follow dosing instructions carefully and to consult with a qualified healthcare professional before using this product.

Additionally, it is important to use 14-Cinnamoyloxycodeinone only as directed and to avoid increasing the dose or frequency of use without discussing the matter with a healthcare professional.

Conclusion:

Overall, 14-Cinnamoyloxycodeinone is a powerful analgesic agent with a variety of potential health benefits. While this compound can provide effective and long-lasting pain relief, it is also associated with a number of potential risks and side effects, particularly when used inappropriately or in high doses.

By using 14-Cinnamoyloxycodeinone only as directed and under the guidance of a qualified healthcare professional, patients can safely and effectively manage pain associated with a variety of medical conditions

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code